Variants associated with Gaucher disease in multiple system atrophy

Annals of Clinical and Translational Neurology

Volumn 2, Issue 4, 2015, Pages 417-426

  Mitsui, Jun ^a   Matsukawa, Takashi ^a   Sasaki, Hidenao ^b   Yabe, Ichiro ^b   Matsushima, Masaaki ^b   Dürr, Alexandra ^c   Brice, Alexis ^c   Takashima, Hiroshi ^d   Kikuchi, Akio ^e   Aoki, Masashi ^e   Ishiura, Hiroyuki ^a   Yasuda, Tsutomu ^a   Date, Hidetoshi ^a   Ahsan, Budrul ^a   Iwata, Atsushi ^a   Goto, Jun ^a   Ichikawa, Yaeko ^a   Nakahara, Yasuo ^a   Momose, Yoshio ^a   Takahashi, Yuji ^a   Hara, Kenju ^f   Kakita, Akiyoshi ^f   Yamada, Mitsunori ^f,g   Takahashi, Hitoshi ^f   Onodera, Osamu ^f   Nishizawa, Masatoyo ^f   Watanabe, Hirohisa ^h   Ito, Mizuki ^h   Sobue, Gen ^h   Ishikawa, Kinya ⁱ   Mizusawa, Hidehiro ⁱ   Kanai, Kazuaki ^j   Hattori, Takamichi ^j   Kuwabara, Satoshi ^j   Arai, Kimihito ^k   Koyano, Shigeru ^l   Kuroiwa, Yoshiyuki ^m   Hasegawa, Kazuko ⁿ   Yuasa, Tatsuhiko ^o   Yasui, Kenichi ^p   Nakashima, Kenji ^p   Ito, Hijiri ^q   Izumi, Yuishin ^r   Kaji, Ryuji ^r   Kato, Takeo ^s   Kusunoki, Susumu ^t   Osaki, Yasushi ^u   Horiuchi, Masahiro ^v   Kondo, Tomoyoshi ^w   Murayama, Shigeo ^x   Hattori, Nobutaka ^y   Yamamoto, Mitsutoshi ^z   Murata, Miho ^aa   Satake, Wataru ^ab   Toda, Tatsushi ^ab   Filla, Alessandro ^ac   Klockgether, Thomas ^ad   Wüllner, Ullrich ^ad   Nicholson, Garth ^ae   Gilman, Sid ^af   Tanner, Caroline M ^ag   Kukull, Walter A ^ah   Stern, Mathew B ^ai   Lee, Virginia M Y ^ai   Trojanowski, John Q ^ai   Masliah, Eliezer ^aj   Low, Phillip A ^ak   Sandroni, Paola ^ak   Ozelius, Laurie J ^al   Foroud, Tatiana ^am   Tsuji, Shoji ^a   more..

^a UNIVERSITY OF TOKYO   (Japan)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d KAGOSHIMA UNIVERSITY   (Japan)

^e TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f NIIGATA UNIVERSITY   (Japan)

^g National Saigata Medical Center   (Japan)

^h NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

ⁱ TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^j CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^k SAKURA NATIONAL HOSPITAL   (Japan)

^l YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^m TEIKYO UNIVERSITY HOSPITAL   (Japan)

ⁿ SAGAMIHARA NATIONAL HOSPITAL   (Japan)

^o Kamagaya General Hospital   (Japan)

^p TOTTORI UNIVERSITY   (Japan)

^q Department of Neurology   (Japan)

^r UNIVERSITY OF TOKUSHIMA   (Japan)

^s YAMAGATA UNIVERSITY   (Japan)

^t KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^u KOCHI MEDICAL SCHOOL   (Japan)

^v ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^w WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^x Tokyo Metropolitan Institute of Gerontology   (Japan)

^y JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^z KAGAWA PREFECTURAL CENTRAL HOSPITAL   (Japan)

^aa National Center Hospital of Neurology and Psychiatry Kodaira   (Japan)

^ab KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^ac UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^ad GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^ae UNIVERSITY OF SYDNEY   (Australia)

^af UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^ag VETERANS AFFAIRS MEDICAL CENTER   (United States)

^ah UNIVERSITY OF WASHINGTON   (United States)

^ai UNIVERSITY OF PENNSYLVANIA   (United States)

^aj UNIVERSITY OF CALIFORNIA   (United States)

^ak MAYO CLINIC   (United States)

^al MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^am INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84945189692     PISSN: None     EISSN: 23289503     Source Type: Journal    
DOI: 10.1002/ACN3.185     Document Type: Article

References (36)

1. Gilman S, Wenning GK, Low PA, et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology 2008;71:670-676.
2. Papp MI, Kahn JE, Lantos PL. Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome). J Neurol Sci 1989;94:79-100.
3. Nakazato Y, Yamazaki H, Hirato J, et al. Oligodendroglial microtubular tangles in olivopontocerebellar atrophy. J Neuropathol Exp Neurol 1990;49:521-530.
4. Tu PH, Galvin JE, Baba M, et al. Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein. Ann Neurol 1998;44:415-422.
5. Wakabayashi K, Yoshimoto M, Tsuji S, Takahashi H. Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy. Neurosci Lett 1998;249:180-182.
6. Al-Chalabi A, Durr A, Wood NW, et al. Genetic variants of the alpha-synuclein gene SNCA are associated with multiple system atrophy. PLoS One 2009;4:e7114.
7. Scholz SW, Houlden H, Schulte C, et al. SNCA variants are associated with increased risk for multiple system atrophy. Ann Neurol 2009;65:610-614.
8. The Multiple-System Atrophy Research Collaboration. Mutations in COQ2 in familial and sporadic multiplesystem atrophy. N Engl J Med 2013;369:233-244.
9. Spillantini MG, Schmidt ML, Lee VM, et al. Alphasynuclein in Lewy bodies. Nature 1997;388:839-840.
10. Goedert M, Spillantini MG. Lewy body diseases and multiple system atrophy as alpha-synucleinopathies. Mol Psychiatry 1998;3:462-465.
11. Kiely AP, Asi YT, Kara E, et al. a-Synucleinopathy associated with G51D SNCA mutation: A link between Parkinson’s disease and multiple system atrophy? Acta Neuropathol 2013;125:753-769.
12. Pasanen P, Myllykangas L, Siitonen M, et al. A novel asynuclein mutation A53E associated with atypical multiple system atrophy and Parkinson’s disease-type pathology. Neurobiol Aging 2014;35:2180.e1-2180.e5.
13. Vidal JS, Vidailhet M, Derkinderen P, et al. Familial aggregation in atypical Parkinson’s disease: A case control study in multiple system atrophy and progressive supranuclear palsy. J Neurol 2010;257:1388-1393.
14. Nee LE, Gomez MR, Dambrosia J, et al. Environmentaloccupational risk factors and familial associations in multiple system atrophy: A preliminary investigation. Clin Auton Res 1991;1:9-13.
15. Fujioka S, Ogaki K, Tacik PM, et al. Update on novel familial forms of Parkinson’s disease and multiple system atrophy. Parkinsonism Relat Disord 2014;20(Suppl 1):S29-S34.
16. Mitsui J, Mizuta I, Toyoda A, et al. Mutations for Gaucher disease confer high susceptibility to Parkinson disease. Arch Neurol 2009;66:571-576.
17. Sidransky E, Nalls MA, Aasly JO, et al. Multicenter analysis of glucocerebrosidase mutations in Parkinson’s disease. N Engl J Med 2009;361:1651-1661.
18. Nalls MA, Duran R, Lopez G, et al. A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies. JAMA Neurol 2013;70:727-735.
19. Goker-Alpan O, Schiffmann R, LaMarca ME, et al. Parkinsonism among Gaucher disease carriers. J Med Genet 2004;41:937-940.
20. Koprivica V, Stone DL, Park JK, et al. Analysis and classification of 304 mutant alleles in patients with type 1 and type 3 Gaucher disease. Am J Hum Genet 2000;66:1777-1786.
21. Tsuji S, Choudary PV, Martin BM, et al. Nucleotide sequence of cDNA containing the complete coding sequence for human lysosomal glucocerebrosidase. J Biol Chem 1986;261:50-53.
22. Stone DL, Carey WF, Christodoulou J, et al. Type 2 Gaucher disease: The collodion baby phenotype revisited. Arch Dis Child Fetal Neonatal Ed 2000;82: F163-F166.
23. Kim MJ, Suh JT, Lee HJ, et al. Simultaneous detection of Gaucher’s disease and renal involvement of non-Hodgkin’s lymphoma: The first Asian case report and a review of literature. Ann Clin Lab Sci 2012;42:293-301.
24. He GS, Grace ME, Grabowski GA. Gaucher disease: Four rare alleles encoding F213I, P289L, T323I, and R463C in type 1 variants. Hum Mutat 1992;1:423-427.
25. Cormand B, Grinberg D, Gort L, et al. Two new mild homozygous mutations in Gaucher disease patients: Clinical signs and biochemical analyses. Am J Med Genet 1997;70:437-443.
26. Amaral O, Marcao A, Sa Miranda M, et al. Gaucher disease: Expression and characterization of mild and severe acid beta-glucosidase mutations in Portuguese type 1 patients. Eur J Hum Genet 2000;8:95-102.
27. Michelakakis H, Dimitriou E, Van Weely S, et al. Characterization of glucocerebrosidase in Greek Gaucher disease patients: Mutation analysis and biochemical studies. J Inherit Metab Dis 1995;18:609-615.
28. Walley AJ, Barth ML, Ellis I, et al. Gaucher’s disease in the United Kingdom: Screening non-Jewish patients for the two common mutations. J Med Genet 1993;30:280-283.
29. Uchiyama A, Tomatsu S, Kondo N, et al. New Gaucher disease mutations in exon 10: A novel L444R mutation produces a new NciI site the same as L444P. Hum Mol Genet 1994;3:1183-1184.
30. Horowitz M, Pasmanik-Chor M, Ron I, Kolodny EH. The enigma of the E326K mutation in acid bglucocerebrosidase. Mol Genet Metab 2011;104:35-38.
31. Segarane B, Li A, Paudel R, et al. Glucocerebrosidase mutations in 108 neuropathologically confirmed cases of multiple system atrophy. Neurology 2009;72:1185-1186.
32. Jamrozik Z, Lugowska A, Slawek J, Kwiecinski H. Glucocerebrosidase mutations p.L444P and p.N370S are not associated with multisystem atrophy, progressive supranuclear palsy and corticobasal degeneration in Polish patients. J Neurol 2010;257:459-460.
33. Sun QY, Guo JF, Han WW, et al. Genetic association study of glucocerebrosidase gene L444P mutation in essential tremor and multiple system atrophy in mainland China. J Clin Neurosci 2013;20:217-219.
34. Srulijes K, Hauser AK, Guella I, et al. No association of GBA mutations and multiple system atrophy. Eur J Neurol 2013;20:e61-e62.
35. Schöndorf DC, Aureli M, McAllister FE, et al. iPSCderived neurons from GBA1-associated Parkinson’s disease patients show autophagic defects and impaired calcium homeostasis. Nat Commun 2014;5:4028.
36. Murphy KE, Gysbers AM, Abbott SK, et al. Reduced glucocerebrosidase is associated with increased a-synuclein in sporadic Parkinson’s disease. Brain 2014;137:834-848.